319 related articles for article (PubMed ID: 8485009)
1. Refractory ascites: definition, pathogenesis and treatment.
Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
[TBL] [Abstract][Full Text] [Related]
2. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of ascites and renal salt retention in cirrhosis.
Palmer BF
J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
[TBL] [Abstract][Full Text] [Related]
4. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
[TBL] [Abstract][Full Text] [Related]
5. Ascites: diagnosis and management.
Hou W; Sanyal AJ
Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
9. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V; Ginès P; Planas R
Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
[TBL] [Abstract][Full Text] [Related]
10. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
11. [Management of ascitis in patients with cirrhosis].
Arfaoui D; Ajmi S
Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
[TBL] [Abstract][Full Text] [Related]
12. [Current ascites therapy].
Ochs A
Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
[TBL] [Abstract][Full Text] [Related]
13. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
14. 'Diuretic-resistant' ascites. Observations on pathogenesis.
Rector WG
Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
[TBL] [Abstract][Full Text] [Related]
15. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
[TBL] [Abstract][Full Text] [Related]
16. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
17. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
Wong F; Bomzon A; Allard J; Liu P; Blendis L
Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
[TBL] [Abstract][Full Text] [Related]
18. Cirrhotic ascites: pathogenesis and management.
Garcia-Tsao G
Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
20. Ascites in liver diseases.
Gentilini P; Laffi G
Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
